These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19509101)

  • 1. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome.
    Barahona MJ; Sucunza N; Resmini E; Fernández-Real JM; Ricart W; Moreno-Navarrete JM; Puig T; Farrerons J; Webb SM
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3365-71. PubMed ID: 19509101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent centripetal fat distribution and metabolic abnormalities in patients in long-term remission of Cushing's syndrome.
    Wagenmakers M; Roerink S; Gil L; Plantinga T; Smit J; Netea-Maier R; Hermus A
    Clin Endocrinol (Oxf); 2015 Feb; 82(2):180-7. PubMed ID: 25323660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble TNFα-receptor 1 as a predictor of coronary calcifications in patients after long-term cure of Cushing's syndrome.
    Barahona MJ; Resmini E; Viladés D; Fernández-Real JM; Ricart W; Moreno-Navarrete JM; Pons-Lladó G; Leta R; Webb SM
    Pituitary; 2015 Feb; 18(1):135-41. PubMed ID: 24728972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome.
    Garrapa GG; Pantanetti P; Arnaldi G; Mantero F; Faloia E
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5301-6. PubMed ID: 11701696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing's syndrome.
    Aulinas A; Ramírez MJ; Barahona MJ; Valassi E; Resmini E; Mato E; Santos A; Crespo I; Bell O; Surrallés J; Webb SM
    PLoS One; 2015; 10(3):e0120185. PubMed ID: 25799396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipokines and cardiovascular risk in Cushing's syndrome.
    Valassi E; Biller BM; Klibanski A; Misra M
    Neuroendocrinology; 2012; 95(3):187-206. PubMed ID: 22057123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma leptin levels in relation to body composition and body fat distribution in patients with Cushing's syndrome].
    Robaczyk M; Krzyzanowiska-Swiniarska B; Andrysiak-Mamos E; Kulig G; Pilarska K
    Pol Arch Med Wewn; 2003 Nov; 110(5):1299-308. PubMed ID: 16737000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing's syndrome.
    Barahona MJ; Sucunza N; Resmini E; Fernández-Real JM; Ricart W; Moreno-Navarrete JM; Puig T; Wägner AM; Rodriguez-Espinosa J; Farrerons J; Webb SM
    J Bone Miner Res; 2009 Nov; 24(11):1841-6. PubMed ID: 19453254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.
    Colao A; Pivonello R; Spiezia S; Faggiano A; Ferone D; Filippella M; Marzullo P; Cerbone G; Siciliani M; Lombardi G
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2664-72. PubMed ID: 10443657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids.
    Resmini E; Farkas C; Murillo B; Barahona MJ; Santos A; Martínez-Momblán MA; Roig O; Ybarra J; Geli C; Webb SM
    Horm Metab Res; 2010 Jul; 42(8):613-8. PubMed ID: 20514604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile.
    Dovio A; Allasino B; Palmas E; Ventura M; Pia A; Saba L; Aroasio E; Terzolo M; Angeli A
    J Clin Endocrinol Metab; 2007 May; 92(5):1803-8. PubMed ID: 17327380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance.
    Puder JJ; Varga S; Kraenzlin M; De Geyter C; Keller U; Müller B
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6014-21. PubMed ID: 16105965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome.
    Krsek M; Silha JV; Jezková J; Hána V; Marek J; Weiss V; Stepán JJ; Murphy LJ
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):350-7. PubMed ID: 15009001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study.
    Ueland T; Kristo C; Godang K; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1492-6. PubMed ID: 12679428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery disease detected by multislice computed tomography in patients after long-term cure of Cushing's syndrome.
    Barahona MJ; Resmini E; Viladés D; Pons-Lladó G; Leta R; Puig T; Webb SM
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1093-9. PubMed ID: 23393183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body Composition is Different After Surgical or Pharmacological Remission of Cushing's Syndrome: A Prospective DXA Study.
    Ceccato F; Boccato M; Zilio M; Barbot M; Frigo AC; Luisetto G; Boscaro M; Scaroni C; Camozzi V
    Horm Metab Res; 2017 Sep; 49(9):660-666. PubMed ID: 28718178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the metabolic phenotypes of Cushing's syndrome and growth hormone deficiency: a study of body composition and energy metabolism.
    Burt MG; Gibney J; Ho KK
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):436-43. PubMed ID: 16584517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin, resistin and leptin response to dietary intervention in diabetic nephropathy.
    Kozłowska L; Rydzewski A; Fiderkiewicz B; Wasińska-Krawczyk A; Grzechnik A; Rosołowska-Huszcz D
    J Ren Nutr; 2010 Jul; 20(4):255-62. PubMed ID: 20537918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of body cell mass in Cushing's syndrome: effect of treatment.
    Pirlich M; Biering H; Gerl H; Ventz M; Schmidt B; Ertl S; Lochs H
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1078-84. PubMed ID: 11889168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.